Pubblicazioni

Elenco delle pubblicazioni scientifiche (ultimi 10 anni)

 

1: Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola MG, Nicchia

GP, Frigeri A, Svelto M. Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4

isoform-dependent sensitivity and specificity. PLoS One. 2013 Nov

15;8(11):e79185. doi: 10.1371/journal.pone.0079185. eCollection 2013. PubMed

PMID: 24260168; PubMed Central PMCID: PMC3829826.

 

 

2: Iaffaldano P, Ruggieri M, Viterbo RG, Mastrapasqua M, Trojano M. The

improvement of cognitive functions is associated with a decrease of plasma

Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. Brain

Behav Immun. 2014 Jan;35:96-101. doi: 10.1016/j.bbi.2013.08.009. Epub 2013 Aug

30. PubMed PMID: 23994630.

 

 

3: Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, Leo A, Mastrapasqua

M, Zoccolella S, Leante R, Livrea P, Logroscino G, Simone IL. Elevated

cerebrospinal fluid neurofilament light levels in patients with amyotrophic

lateral sclerosis: a possible marker of disease severity and progression. Eur J

Neurol. 2012 Dec;19(12):1561-7. doi: 10.1111/j.1468-1331.2012.03777.x. Epub 2012

Jun 11. PubMed PMID: 22680408.

 

 

4: de Tommaso M, Ceci E, Pica C, Trojano M, Delussi M, Franco G, Livrea P,

Ruggieri M. Serum levels of N-acetyl-aspartate in migraine and tension-type

headache. J Headache Pain. 2012 Jul;13(5):389-94. doi: 10.1007/s10194-012-0448-3.

Epub 2012 Apr 17. PubMed PMID: 22527035; PubMed Central PMCID: PMC3381063.

 

 

5: Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Specchio LM,

Martino G, Trojano M, Furlan R, Avolio C. Monocytes P2X7 purinergic receptor is

modulated by glatiramer acetate in multiple sclerosis. J Neuroimmunol. 2012

Apr;245(1-2):93-7. doi: 10.1016/j.jneuroim.2012.02.002. Epub 2012 Feb 26. PubMed

PMID: 22370183.

 

 

6: Ruggieri M, Serpino C, Ceci E, Sciruicchio V, Franco G, Pica C, Trojano M,

Livrea P, de Tommaso M. Serum levels of N-acetylaspartate in Huntington's

disease: preliminary results. Mov Disord. 2012 Feb;27(2):329-30. doi:

10.1002/mds.23974. Epub 2011 Oct 28. PubMed PMID: 22038921.

 

 

7: Simone IL, Ruggieri M, Tortelli R, Ceci E, D'Errico E, Leo A, Zoccolella S,

Mastrapasqua M, Capozzo R, Livrea P, Logroscino G. Serum N-acetylaspartate level

in amyotrophic lateral sclerosis. Arch Neurol. 2011 Oct;68(10):1308-12. doi:

10.1001/archneurol.2011.217. PubMed PMID: 21987545.

 

 

8: Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V,

Mastrapasqua M, Frigeri A, Amato MP, Hakiki B, Ghezzi A, Lugaresi A, De Luca G,

Patti F, D'Amico E, Sola P, Simone AM, Svelto M, Livrea P, Trojano M. Serum and

CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis

optica. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1355-9. doi:

10.1136/jnnp.2011.241836. Epub 2011 May 27. PubMed PMID: 21622936.

 

 

9: Ruggieri M, Tortorella C, Ceci E, Paolicelli D, Solfrizzi V, Di Bitonto G,

Pica C, Mastrapasqua M, Livrea P, Trojano M. Age-related changes of serum

N-acetyl-aspartate in healthy controls. Age Ageing. 2011 May;40(3):391-5. doi:

10.1093/ageing/afr021. Epub 2011 Mar 20. PubMed PMID: 21422012.

 

 

10: Pisani F, Mastrototaro M, Rossi A, Nicchia GP, Tortorella C, Ruggieri M,

Trojano M, Frigeri A, Svelto M. Identification of two major conformational

aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem.

2011 Mar 18;286(11):9216-24. doi: 10.1074/jbc.M110.123000. Epub 2011 Jan 6.

PubMed PMID: 21212277; PubMed Central PMCID: PMC3059066.

 

 

11: Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA,

Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F,

Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V,

Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK,

Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S,

Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive

PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge

T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J,

Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand

T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van

Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R,

Wildemann B, Yang C, Yao K, Teunissen CE. Neurofilament ELISA validation. J

Immunol Methods. 2010 Jan 31;352(1-2):23-31. doi: 10.1016/j.jim.2009.09.014. Epub

2009 Oct 24. PubMed PMID: 19857497.

 

 

12: Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia

A, Trojano M, Frigeri A, Svelto M. Aquaporin-4 orthogonal arrays of particles are

the target for neuromyelitis optica autoantibodies. Glia. 2009

Oct;57(13):1363-73. doi: 10.1002/glia.20855. PubMed PMID: 19229993.

 

 

13: Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM,

Livrea P, Trojano M, Avolio C. Combination treatment of Glatiramer Acetate and

Minocycline affects phenotype expression of blood monocyte-derived dendritic

cells in Multiple Sclerosis patients. J Neuroimmunol. 2008 Jul 15;197(2):140-6.

doi: 10.1016/j.jneuroim.2008.04.032. Epub 2008 Jun 13. PubMed PMID: 18555539.

 

 

14: Lucivero V, Prontera M, Mezzapesa DM, Petruzzellis M, Sancilio M, Tinelli A,

Di Noia D, Ruggieri M, Federico F. Different roles of matrix metalloproteinases-2

and -9 after human ischaemic stroke. Neurol Sci. 2007 Aug;28(4):165-70. Epub 2007

Aug 10. PubMed PMID: 17690845.

 

 

15: Ruggieri M, Avolio C, Livrea P, Trojano M. Glatiramer acetate in multiple

sclerosis: a review. CNS Drug Rev. 2007 Summer;13(2):178-91. Review. PubMed PMID:

17627671.

 

 

16: Ruggieri M, Avolio C, Scacco S, Pica C, Lia A, Zimatore GB, Papa S, Livrea P,

Trojano M. Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2,

Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients. J

Neurol. 2006 Feb;253(2):231-6. Epub 2005 Sep 30. PubMed PMID: 16184340.

 

 

17: Avolio C, Filippi M, Tortorella C, Rocca MA, Ruggieri M, Agosta F, Tomassini

V, Pozzilli C, Stecchi S, Giaquinto P, Livrea P, Trojano M. Serum MMP-9/TIMP-1

and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different

magnetic resonance imaging measures of disease activity during IFN-beta-1a

treatment. Mult Scler. 2005 Aug;11(4):441-6. PubMed PMID: 16042227.

 

 

18: Avolio C, Giuliani F, Liuzzi GM, Ruggieri M, Paolicelli D, Riccio P, Livrea

P, Trojano M. Adhesion molecules and matrix metalloproteinases in Multiple

Sclerosis: effects induced by Interferon-beta. Brain Res Bull. 2003 Aug

15;61(3):357-64. Review. PubMed PMID: 12909305.

 

 

19: Avolio C, Ruggieri M, Giuliani F, Liuzzi GM, Leante R, Riccio P, Livrea P,

Trojano M. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis

subtypes. J Neuroimmunol. 2003 Mar;136(1-2):46-53. PubMed PMID: 12620642.